NHS Patient Safety Technology Provider Patientrack Becomes Alcidion

Alcidion LtdA technology company that has helped NHS hospitals in England and Scotland to quickly identify and respond to their sickest patients, will now be known as Alcidion. Patientrack, which is known for providing technology for electronic patient observations and early warnings of patient deterioration to the NHS, first announced it had been acquired by Alcidion Group Limited in 2018.

The company's product - also called Patientrack - will still be available to NHS hospitals, which have recordedsignificant gains in patient safety by using the technology - including reductions in cardiac arrests, mortality, lengths of stay, and admissions to intensive care. Hospitals have also innovated with the Patientrack technology to tackledeadly conditions, including acute kidney injury and sepsis.

Whilst the Patientrack product will remain fully supported with the same dedicated UK team, the company has now been formally rebranded as Alcidion, to reflect its wider offering of cutting edge technology to the NHS, designed to transform healthcare.

Donald Kennedy, UK general manger, Alcidion, said: “We are building on a remarkable legacy of collaboration with the NHS that has delivered a big impact on patient safety.

"As Alcidion, we have the ability to take this to the next level, and to offer the NHS a much wider set of digital tools. These have been designed to not only support the next generation of patient safety, but to streamline patient journeys, increase operational efficiency, inform clinical decision making and help hospitals to understand their data.

"We are already doing all of this with early NHS pioneers, and so it is only fitting that we adopt our new identity that reflects our even more compelling offer to the NHS."

Dartford and Gravesham NHS Trust became the first UK organisation to procure the full Alcidion product suite in a five-year partnership announced earlier in 2019. The trust is deploying ahealth technology platformthat will transform patient safety and clinical efficiency for its hospitals and its local healthcare system partners and will help the trust realise its mission to become a self-made digital exemplar.

Alcidion provides solutions spanning predictive analytics, patient flow, clinical messaging, integration support, and clinical decision making. The Patientrack product will continue to perform its electronic observations, patient assessments and early warning role, as part of an integrated offering with other Alcidion products. This includes the Miya platform, which provides decision intelligence software that consolidates real-time data from disparate healthcare IT systems and pushes decision intelligence and guidance to users via mobile devices.

The Miya platform is cloud based with analytics tools to help professionals manage clinical workflows and reduce avoidable injury. It provides logistics tools to give valuable time back to the care team.

Smartpage, the company's clinical messaging system is used in hospitals to improve communication and safety in the clinical environment.

Kate Quirke, managing director of Alcidion, said: "This is about transforming healthcare together, by empowering doctors and nurses to deliver the best possible outcomes for their patients. We are already working with the NHS to use technology in a way that delivers insights to clinicians so they can prevent and intervene.

"Healthcare professionals need to understand how their patients are progressing and need to have information about their current status and potential risk. Alcidion has rapidly developed in the last 12 months in meeting these challenges, with acquisitions allowing us to grow into a leading informatics company helping healthcare providers throughout the world.

"People in the NHS have come to know Patientrack as an important innovator in the patient safety arena, and we now look forward to developing that innovation to a growing number of areas, as we continue to partner with one of the most respected health institutions in the world to deliver the best for its patients."

About Alcidion Ltd

Alcidion Ltd (ASX:ALC) has a simple purpose, that is, to make healthcare better with smart, intuitive solutions that meet the needs of hospital and allied healthcare, worldwide. Alcidion incorporates three healthcare software companies previously known as Alcidion Corporation, Patientrack and Smartpage, and MKM Health, an IT solutions and services provider. Each company brings a complementary set of products and skills that create a unique offering in the global healthcare market; solutions that support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes. With over 25 years of combined healthcare experience, the Alcidion Group of companies brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...